Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’
Drug Discovery World
JANUARY 21, 2024
It is enabling computational protein design for vaccine immunogen discovery, and high-throughput and high-definition assays for quicker and more comprehensive characterisation of vaccine candidates and vaccine-elicited immunity. Is pharma’s commercial model dying?
Let's personalize your content